35282079|t|Activation of the AKT/GSK-3beta/beta-catenin pathway via photobiomodulation therapy promotes neural stem cell proliferation in neonatal rat models of hypoxic-ischemic brain damage.
35282079|a|Background: Hypoxic-ischemic brain damage (HIBD) significantly affects neurodevelopment in infants and is a leading cause of severe neurological morbidity and mortality in neonates. Our previous study found that photobiomodulation therapy (PBMT) improves the impaired spatial learning and memory of HIBD rat models. However, the neuroprotective mechanism conferred by PBMT in HIBD is unclear. Methods: In the present study, HIBD model rats were treated with PBMT at 5 mW/cm2 per day in the dark for 14 days (10 min each day), and primary neural stem cells (NSCs) after oxygen-glucose deprivation (OGD) were treated with PBMT for 10 min at 1, 5, 10, and 20 mW/cm2 in the dark. PBMT promoted hippocampal neural stem cell (NSC) proliferation in vivo and in vitro. Results: Mechanistically, PBMT upregulated phosphatidylinositol 3 kinase (PI3K), phosphorylated protein kinase B (p-AKT), phosphorylated glycogen synthase kinase 3 beta (p-GSK-3beta), beta-catenin, and cyclin D1 expression in vivo and in vitro, promoting NSC proliferation. Furthermore, both LY294002 (a PI3K inhibitor) and IWR-1 (a Wnt/beta-catenin inhibitor) inhibited the PBMT promotion of NSC proliferation after OGD and suppressed beta-catenin and cyclin D1 expression in vitro. Conclusions: PBMT improved the spatial learning and memory of HIBD rats and promoted hippocampal NSC proliferation through the AKT/GSK-3beta/beta-catenin pathway.
35282079	18	21	AKT	Gene	24185
35282079	22	31	GSK-3beta	Gene	84027
35282079	32	44	beta-catenin	Gene	84353
35282079	136	139	rat	Species	10116
35282079	150	179	hypoxic-ischemic brain damage	Disease	MESH:D002534
35282079	193	222	Hypoxic-ischemic brain damage	Disease	MESH:D002534
35282079	224	228	HIBD	Disease	MESH:D002534
35282079	440	476	impaired spatial learning and memory	Disease	MESH:D008569
35282079	480	484	HIBD	Disease	MESH:D002534
35282079	485	488	rat	Species	10116
35282079	557	561	HIBD	Disease	MESH:D002534
35282079	605	609	HIBD	Disease	MESH:D002534
35282079	616	620	rats	Species	10116
35282079	750	776	oxygen-glucose deprivation	Chemical	-
35282079	778	781	OGD	Chemical	-
35282079	985	1014	phosphatidylinositol 3 kinase	Gene	85243
35282079	1058	1061	AKT	Gene	24185
35282079	1079	1110	glycogen synthase kinase 3 beta	Gene	84027
35282079	1114	1123	GSK-3beta	Gene	84027
35282079	1126	1138	beta-catenin	Gene	84353
35282079	1144	1153	cyclin D1	Gene	58919
35282079	1234	1242	LY294002	Chemical	MESH:C085911
35282079	1266	1271	IWR-1	Chemical	-
35282079	1275	1278	Wnt	Gene	114487
35282079	1279	1291	beta-catenin	Gene	84353
35282079	1359	1362	OGD	Chemical	-
35282079	1378	1390	beta-catenin	Gene	84353
35282079	1395	1404	cyclin D1	Gene	58919
35282079	1488	1492	HIBD	Disease	MESH:D002534
35282079	1493	1497	rats	Species	10116
35282079	1553	1556	AKT	Gene	24185
35282079	1557	1566	GSK-3beta	Gene	84027
35282079	1567	1579	beta-catenin	Gene	84353
35282079	Association	MESH:D002534	24185
35282079	Association	MESH:D002534	84027
35282079	Negative_Correlation	MESH:C085911	84353
35282079	Association	MESH:D002534	84353
35282079	Association	84027	84353
35282079	Negative_Correlation	MESH:C085911	58919
35282079	Association	24185	84353

